$NVCR 3 SEC Filings

Filed On	Filing
06 Jan 2025	Form 3: Brackmann Christoph, CFO Holds 11,200 shares of Ordinary Shares
09 Oct 2024	Form 3: Paravasthu Mukund, Chief Operating Officer Holds 3,663 shares of Ordinary Shares
12 Jan 2024	Form 3: Leonard Frank X, EVP, Pres., Novocure Oncology Holds 45,268 shares of Ordinary Shares
11 Jan 2024	Form 3: Leupin Nicolas, Chief Medical Officer No securities owned
20 Dec 2023	Form 3: Giladi Moshe, Chief Science Officer Holds 7,008 shares of Ordinary Shares
02 Nov 2023	Form 3: Puri Michal Nath, Chief Human Resources Officer No securities owned
30 Mar 2023	Form 3: Stafford Kristin, Director No securities owned
03 Mar 2023	Form 3: Ocean Allyson J, Director
14 Apr 2022	Form 3: Ben Arye Barak, General Counsel Holds 4,223 shares of Ordinary Shares
03 Sep 2021	Form 3: Burke William Patrick, Chief Human Resources Officer Holds 10,283 shares of Ordinary Shares
12 Feb 2021	Form 3: Scannell Timothy J, Director Holds 75 shares of Ordinary Shares
10 Sep 2020	Form 3: Leonard Frank X, Chief Development Officer Holds 59,811 shares of Ordinary Shares
10 Sep 2020	Form 3: Cordova Ashley, Chief Financial Officer Holds 7,348 shares of Ordinary Shares
07 May 2020	Form 3: Weinberg Uri, Chief Science Officer Holds 2,773 shares of Ordinary Shares
01 Aug 2019	Form 3: Benaim Ely, Chief Medical Officer Holds 12,616 shares of Restricted Share Units
06 Aug 2018	Form 3: Hilleman Jeryl L, Director
11 Jul 2018	Form 3: Shah Pritesh, Chief Commercial Officer Holds 5,231 shares of Ordinary Shares
11 Jun 2018	Form 3: McCoy Sherilyn S, Director
11 Jun 2018	Form 3: Hung David, Director
19 May 2017	Form 3: Madden Martin J., Director

Comments